IDH-MUTANT GRADE 4 ASTROCYTOMA
Clinical trials for IDH-MUTANT GRADE 4 ASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new IDH-MUTANT GRADE 4 ASTROCYTOMA trials appear
Sign up with your email to follow new studies for IDH-MUTANT GRADE 4 ASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cold virus hijacked to attack returning brain tumors in early trial
Disease control Recruiting nowThis early-phase trial tests a modified cold virus (DNX-2401) that is loaded into donor stem cells and injected into the brain's blood supply to target recurrent high-grade gliomas. The virus is designed to infect and kill cancer cells while leaving healthy cells alone. The study…
Matched conditions: IDH-MUTANT GRADE 4 ASTROCYTOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Genetically modified immune cells take on deadly brain tumors
Disease control Recruiting nowThis early-stage trial tests genetically engineered natural killer (NK) cells in 25 people with recurrent glioblastoma, an aggressive brain cancer. The cells are designed to resist the tumor's defenses. The main goal is to find a safe dose and check for side effects, while also w…
Matched conditions: IDH-MUTANT GRADE 4 ASTROCYTOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC